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Parsimonious Gene Correlation Network Analysis (PGCNA):
a tool to deﬁne modular gene co-expression for reﬁned
molecular stratiﬁcation in cancer
Matthew A. Care 1,2, David R. Westhead2 and Reuben M. Tooze 1
Cancers converge onto shared patterns that arise from constraints placed by the biology of the originating cell lineage and
microenvironment on programs driven by oncogenic events. Here we deﬁne consistent expression modules reﬂecting this structure
in colon and breast cancer by exploiting expression data resources and a new computationally efﬁcient approach that we validate
against other comparable methods. This approach, Parsimonious Gene Correlation Network Analysis (PGCNA), allows comparison of
network structures between these cancer types identifying shared modules of gene co-expression reﬂecting: cancer hallmarks,
functional and structural gene batteries, copy number variation and biology of originating lineage. These networks along with the
mapping of outcome data at gene and module level provide an interactive resource that generates context for relationships
between genes within and between such modules. Assigning module expression values (MEVs) provides a tool to summarize
network level gene expression in individual cases illustrating potential utility in classiﬁcation and allowing analysis of linkage
between module expression and mutational state. Exploiting TCGA data thus deﬁnes both recurrent patterns of association
between module expression and mutation at data-set level, and exempliﬁes the polarization of mutation patterns with the leading
edge of module expression at individual case level. We illustrate the scalable nature of the approach within immune response
related modules, which in the context of breast cancer demonstrates the selective association of immune subsets, in particular mast
cells, with the underlying mutational pattern. Together our analyses provide evidence for a generalizable framework to enhance
molecular stratiﬁcation in cancer.
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INTRODUCTION
A primary driver in tumor classiﬁcation is enhanced precision
through molecular characterization. Such analysis provides an
increasingly complex view of individual tumor biology,1 resulting
in the concept of combinatorial characterization using multiple
platforms. An extension is provided by pan-cancer classiﬁcation
where cases associated with key molecular features are combined
potentially across the boundaries of conventional classiﬁcation.2
Gene expression-based classiﬁcations have deﬁned both prog-
nostically and pathogenetically distinct cancer subtypes,3–6 which
have preferential association with mutational and cytogenetic
proﬁles.7 Use of reduced sets of genes allows recognition of
subtypes in applied classiﬁcations.8,9 The cancer hallmark para-
digm postulates that aberrantly regulated features assemble in
modular fashion to promote malignancy.10 Thus, an integrated
assessment of these features might also take a modular approach
within individual cancers.
With multiple data-sets the pattern of correlation between
individual pairs of genes can be used to determine intrinsic
modules of gene co-expression.11 Exemplifying how modular
patterns of co-expression can be identiﬁed within the overall
proﬁle of a tumor, gene expression allows inference of tumor
inﬁltrating immune populations.12,13 Existing expression data-sets
provide an extensive resource for individual types of cancer, which
sit alongside multiparameter analysis across diverse cancer types
in resources such as TCGA. We considered that a network analysis
of cancer expression data could provide added value by
generating a visual structure that contextualizes patterns of gene
co-expression across large data-sets, but given the complexity of
expression data this would depend on efﬁcient reduction in the
number of edges connecting genes in the network. A test for such
a data-led approach lies in the ability to resolve modules of co-
expressed genes associated with known meaningful biology
within and between cancer types. We reasoned that by addressing
these goals using an unsupervised method, without prior
assumptions, we would be able to assess the resulting networks
against pre-existing paradigms and as a platform for molecular
stratiﬁcation of cancer. In the latter context we envisaged
mapping the discovered modules onto gene expression data-
sets to generate module ‘ﬁngerprints’ per sample/patient and
using these derived ‘ﬁngerprints’ to study relationships between
module biology and external factors such as gene mutation state.
Providing a conceptual framework for this study, previous
successful methods for network analysis have generated sig-
niﬁcant insights in model systems and clinical data.14–17 However,
such approaches are not intrinsically designed to generate
networks across multiple data-sets. Furthermore, a common
challenge in extracting meaning from network-based analysis is
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the potentially very high density of connectivity. Although this can
be successfully negotiated using approaches that focus onto
modular patterns of gene expression.18
Here we test a conceptually simple, parsimonious approach to
the problem of connectivity reduction as a means of deriving
modular expression networks across the gene expression data
resource for breast and colon cancer. We test the utility of the
resulting networks as a platform to explore multi-parameter data
such as TCGA.
RESULTS
Parsimony enhances gene expression network clustering
A challenge in analyzing gene co-expression patterns is how to
exploit multiple data-sets, with potentially very large numbers of
genes and correlations, to derive an integrated and tractable
visualization of gene co-expression patterns, while also generating
modules of gene co-expression that can be used in downstream
analyses of related data. We reasoned that a parsimonious
approach in which only a restricted number of the most signiﬁcant
correlations (edges) per gene (node) are retained might provide a
focusing effect in network analysis. To address this, we developed
a method in which the correlation patterns of gene co-expression
are integrated across multiple data-sets, by ﬁrst deriving a per-
data-set correlation matrix, and then combing these to generate a
merged correlation matrix based on the median correlations and
p-values across different data-sets. A particular challenge lies in
the high degree of connectivity of these data, resulting in difﬁculty
interpreting the relationships between nodes. To address this
issue, we conceived of a simple approach in which for each gene
only the edges reﬂecting the most highly correlated genes are
retained (Edge Per Gene: EPG; where EPG3= retaining 3 edges per
gene). These are assembled into a matrix in which a gene may
retain additional correlations if it represents a common partner of
other genes in the matrix (Supplemental Fig. 1 for methods
outline and Supplemental Methods for further details; both in
Supplemental Materials). We applied this approach to expression
data-sets for breast cancer (BRCA, n= 26 expression data-sets) and
colorectal cancer (CRC, n= 11 expression data-sets). Applying the
radical edge reduction thresholds of EPG3—EPG10 resulted in a
linear relationship with total edges in the network, reducing edges
by a factor of between 250 (EPG10) to 900-fold (EPG3)
(Supplemental Table 1). The resulting parsimonious correlation
matrices were tested in network generation.
Clusters of gene co-expression were derived from correlation
matrices using three approaches: hierarchical clustering, K-means
clustering or a computationally efﬁcient network tool, fast
unfolding of communities in large networks (FastUnfold).19 In
each instance clusters were generated from matrices in which
genes retained all edges (edges with p-value >0.05 set to zero and
thus removed) or parsimonious matrices (EPG3—EPG10; Supple-
mental Table 1). To compare the resulting partitioning of the data,
the clusters of co-expression (subsequently referred to as
modules, Supplemental Table 2) were then tested for the
separation of known biology, based on enrichment of ontology
and signature terms. This was assessed using a scaled cluster
enrichment score (SCES), which takes into account the signiﬁcance
of enrichment of ontology and signature terms within a module,
the extent to which the enrichment of signature or ontology term
is speciﬁc to an individual module rather than being shared across
multiple modules, and the balance of gene number associated
with individual modules. Strikingly, when using EPG parsimonious
matrices, the network method (FastUnfold) provided the most
signiﬁcant enrichment and segregation of ontology terms. This
was a particular feature of the combination of FastUnfold with
parsimonious matrices as applying FastUnfold to the total
correlation matrix without parsimonious edge reduction resulted
in poor separation of the data (Fig. 1a). For each cancer type,
decreasing the retained edge per gene (minimum EPG3) led to an
increasing number of resolved modules (Supplemental Fig. 2a).
This corresponded to an improved segregation of biology
between modules across both cancers (Fig. 1a). Indeed, there
was no signiﬁcant beneﬁt to retaining more than 3 edges per
gene (EPG3), while at this level of edge reduction the number of
modules remained manageable for downstream analysis (Supple-
mental Fig. 2a). Notably the use of parsimonious matrices in
conjunction with FastUnfold outperformed both hierarchical and
k-means clustering of the data even where all edges were
retained. While parsimonious matrices did not confer beneﬁt to
the separation of data when using these other clustering methods.
For the EPG3/FastUnfold combination robustness was tested for
the best 100 clusterings, showing that for each cancer type
modules retained a high proportion of the same genes across
different clustering runs (Supplemental Fig. 2b, c). Network
solutions generated with the combination of FastUnfold and
parsimonious matrices were scale-free across all the EPG thresh-
olds tested (Supplemental Fig. 2d). This is not the case for
application of FastUnfold to the total untrimmed correlation data
(ﬁltered by hard threshold; Supplemental Fig. 2e) which also failed
to generate effective resolution of biology between modules.
Thus, we concluded that a combination of edge reduction with
the FastUnfold approach enhanced the resulting network solution
in gene correlation data.
Next to assess whether EPG edge reduction with FastUnfold
provides a particular advantage we compared different edge
reﬁnement methods. This compared the EPG3 approach against
iPCC,20 a power function or the sigmoid functions of the Weighted
Gene Correlation Network Analysis package (WGCNA),15 as input
into FastUnfold. Because WGCNA is mainly aimed at single data-
set analysis we evaluated these four approaches using represen-
tative large expression data-sets for BRCA and CRC. The results
were compared in terms of the retained edge number (edges
<0.01 removed; providing an indication of the degree of edge
reduction), the total number of modules resolved in the data, the
number of modules with >5 genes per module (as a reﬂection of
balanced module size), the median module SCES as indicator of
separation of biology between modules, the median sum of SCES
as an indicator of the total enrichment of biology across the
network, and the percentage of genes connected in the network.
Overall when compared against the other methods the combina-
tion of EPG3 with FastUnfold provided both a suitable module
number and size for downstream evaluation and the greatest sum
of biological signature enrichments across the network. Neither
iPCC or power function produced a substantial edge reduction
and when used in combination with FastUnfold this resulted in
separation of the data into 2–4 modules, which provides
insufﬁcient resolution of underlying biology (Supplemental Figs
3 and 4). In contrast, the Sigmoid function at higher μ thresholds
effectively reduced edge number (Fig. 1b, c, and Supplemental
Figs 3 and 4) but did so at the expense of generating large
numbers of very small modules with less than 5 gene members
per module, as well as a progressive increase in the percentage of
orphan genes unconnected to the network. The median sum SCES
increased for the Sigmoid function at higher μ levels yet remained
below that of the EPG3 network, with the latter also retaining
100% gene connectivity as compared to 32/61% for the highest
Sigmoid μ in BRCA/CRC respectively. We therefore conclude that
the combination of EPG3 matrices clustered with FastUnfold
provides added value, and refer to this combination as
Parsimonious Gene Correlation Network Analysis (PGCNA).
In order to provide a further assessment of the potential value
of this approach we tested its relative performance against the
WGCNA package as a whole, which has been shown to provide a
very effective tool for clustering diverse data types,15 and was
used for comparison for this reason. Since WGCNA is primarily
M.A. Care et al.
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intended for analyzing single sets of expression data and has not
been speciﬁcally designed to handle a correlation matrix of the
type generated by merging multiple data-sets as applied here, we
again performed this comparative analysis using single
representative expression data-sets. WGCNA uses the concept of
scale-free networks to aid parameter selection. As noted above,
PGCNA generated scale-free topologies across all EPG thresholds
tested (Supplemental Fig. 2d). Comparing gene ontology and
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Fig. 1 Radical edge reduction enhances the resolution of biology in gene co-expression modules. a Enrichment of gene ontology and
signatures was assessed using a scaled cluster enrichment score (SCES) and compared between data clustering generated with FastUnfold,
Hierarchical clustering or k-means clustering using either the total correlation data (All) or parsimonious matrices with edges per gene (EPG)
thresholds between 3 and 10. Violin plots display the distribution along with median (blue square) and the IQR. b, c density plots of the
module size (gene-number; x-axis) vs module SCES (Scaled Cluster Enrichment Score; see methods; y-axis) across the 100 best clustering for
EPG3 (Edge Per Gene 3) or the WGCNA sigmoid adjacency function varying the shift (μ, 0.1, 0.5 and 0.9). b BRCA data and c CRC data. Beneath
the graph the results are displayed in tabular form, showing the median module number, median modular number with gene membership
>5, edge number retained after ﬁltering (edges <0.01 removed), median sum of module SCES, median module SCES, and the percentage of
connected genes (after ﬁltering; edges <0.01 removed)
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signature enrichment using the SCES, indicated a greater
enrichment for the PGCNA solutions relative to WGCNA (Supple-
mental Fig. 5). Considering the stability of module gene member-
ship across soft threshold levels employed in WGCNA and EPG
levels in PGCNA, the PGCNA method demonstrated a higher
degree of stability for gene membership (Supplemental Figs 6–9).
Of note, in performing the technical comparison of the clustering
approaches the EPG/FastUnfold combination (PGCNA) was also
highly efﬁcient in terms of computational time and memory usage
(Supplemental Methods). Thus the combination of parsimonious
edge reduction and FastUnfold analysis in addition to providing
enhanced resolution of biology between network modules, can
provide beneﬁts in terms of computational efﬁciency.
Biology of network modules and mapping to expression-based
cancer classiﬁcations
The above analysis established that PGCNA provided an effective
tool for analysis of gene co-expression providing advantages
relative to pre-existing methods; producing tractable networks
that allow contextualization of all nodes and edges used in
network generation and that clusters these into a small number
(<50) of biologically distinct modules. To further evaluate the
utility of this approach the optimum PGCNA clustering based on
SCES was taken forward for detailed downstream analysis for each
cancer type.
Initially the networks were visualized as an interactive web-
based resource (Fig. 2a, b). To enhance network utility additional
factors were overlaid providing inter-related visualizations of the
data viewed through the networks (Supplemental Fig. 10 & http://
pgcna.gets-it.net/). Indeed, one of the impacts of radical edge
reduction is the generation of sparser and visually navigable
networks, in which nonetheless all genes remain connected and
all edges used in network generation can be visualized. This is
particularly the case when viewed as an interactive resource,
which provides a context for assessing the relationships of gene
co-expression, for example, in relation to genes linked to existing
expression-based cancer classiﬁcation schemes.
Detection of BRCA intrinsic sub-classes has been reﬁned into
expression-based tools such as the PAM50 classiﬁer.4,5,8 Mapping
genes linked to these intrinsic classes onto the network identiﬁes
BRCA_M6 as the luminal module (Fig. 2a [i], Supplemental Fig.
10a–c, online). Genes associated with ERBB2 ampliﬁed breast
cancer map on to BRC_M5 (Fig. 2a [ii]), epithelial genes deﬁning
basal breast cancer overlap with those linked to normal-like breast
cancers and map onto module BRCA_M14 (Fig. 2a [iii]). While
genes linked to cell proliferation which provide a shared feature of
Luminal B and Basal type breast cancers map onto BRCA_M7 (Fig.
2a [iv]). An example here of the networks providing context for
patterns of gene expression is the close linkage within the
network between BRCA_M14 and BRCA_M7, which together
encompass genes that deﬁne basal type breast in the PAM50
classiﬁcation.
The CRC consensus molecular subtype classiﬁcation recognizes
four subtypes6: CMS2 containing genes linked to canonical
enterocyte-like differentiation maps onto module CRC_M3 (Fig.
2b [i]); CMS3 reﬂects goblet-cell and metabolic differentiation and
maps onto CRC_M7 (Fig. 2b [ii]); CMS1 identiﬁes microsatellite
unstable cancers through interferon response genes and maps
onto CRC_M32 (Fig. 2b [iii]); and CMS4 encompassing mesench-
ymal dominant CRC maps onto CRC_M8 (Fig. 2b [iv]) (Supple-
mental Fig. 10d–f, online). Again, in this network the context of
gene expression relationships between enterocyte and goblet cell
differentiation is illustrated by the proximity of these modules in
the network, and their distinct separation from the mesenchymal
module. Therefore, the PGCNA networks successfully place current
paradigms of expression-based classiﬁcation in BRCA and CRC in
the context of wider expression patterns for each cancer.
Assessment of network clustering success was based on the
enrichment and segregation of gene signatures between the
resulting modules. These enrichments (Supplemental Table 3
(BRCA) & 4 (CRC)) were summarized to illustrate the most
signiﬁcantly enriched ontology and signature terms between
modules using heatmaps. The purity of segregated biology was
reﬂected in the separation of enriched signatures between
individual modules (Fig. 3a, b & Supplemental Fig. 11a, b). A
summary designation was assigned to each module based on a
selectively enriched term.
We next tested whether recurrent features of cancer biology
could be identiﬁed in the comparison of modules between the
cancer types. Pairwise comparison demonstrated a high degree of
similarity at the level of module gene membership (Fig. 3c,
Supplemental Fig. 11c). In this gene level comparison, the majority
of modules viewed from either cancer perspective had one
primary corresponding module, as assessed by the maximal z-
score for overlap of gene membership, and the majority of
modules overall had at least one module with very highly
signiﬁcant overlap. Where a module in one cancer type such as
CRC_M17 had multiple highly signiﬁcantly corresponding mod-
ules in BRCA (BRCA_M3, M16, M28, M39, M37), the BRCA modules
BRCA
a
CRC
b
i
ii
iiiiv i
ii
iii
iv
Fig. 2 Network visualization for BRCA and CRC. a BRCA network with modules color-coded, modules overlapping signiﬁcantly with those in
CRC share a common color. Modules corresponding to intrinsic BRCA classiﬁcation (i) luminal (BRCA_M6), (ii) ERBB2/HER2 (BRCA_M5), (iii)
basal/normal (BRCA_M14) and (iv) cell cycle (BRCA_M7). b CRC network, highlighted modules correspond to consensus molecular subtypes of
CRC (i) CMS2-enterocyte (CRC_M3), (ii) CMS3-metabolic/goblet (CRC_M7), (iii) CMS1-hypermutated (CRC_M32) and (iv) CMS4-mesenchymal
(CRC_M8). Fully annotated versions in Supplemental Fig. 10, and http://pgcna.gets-it.net/
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Fig. 3 Module biology and between cancer analysis identiﬁes principles of gene co-expression. Heatmaps of gene signature enrichment
between modules a BRCA, b CRC. Signiﬁcant enrichment or depletion illustrated on red/blue scale, x-axis (modules) and y-axis (signatures).
Hierarchical clustering according to gene signature enrichment (using top 15 signatures per module; FDR <0.05). Scalable version in
Supplemental Fig. 11a, b. c, d Module relationship between cancers analyzed using hypergeometric test displayed as pairwise comparison
matrix. Signiﬁcance of overlap displayed as p-values on indicated color scale (p-values <0.001); overlap by c module gene membership, d
enriched gene signatures. Gray side bars illustrate maximal signiﬁcance for module match. Module class Cancer-Hallmark: gray, Cell-of-origin:
blue, Chromosome-Region: cyan, Functional-Gene-Battery: yellow, Structural-Gene-Battery: orange and Unassigned: white (Scalable version in
Supplemental Fig. 11c, d)
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reciprocally had the CRC module, in this case CRC_M17, as their
primary corresponding module. Thus, the modules in the alternate
cancer types in some instance reﬂected a separation into more
reﬁned structure. By contrast very few modules generated in
either cancer type lacked a signiﬁcant corresponding module.
Given that the network modules are derived in an agnostic fashion
from multiple data-sets of entirely disparate cancer types, the level
of overlap in gene membership generated by this approach is
notable. This supports the argument that these modules of gene
co-expression identify recurrent and stable clusters of gene co-
expression.
We next extended the analysis to consider the overlap of
biology associated with network modules comparing the enrich-
ment of ontologies and signatures associated with each module
irrespective of the genes driving that enrichment. This generated
a similar but more diverse pattern than that seen at gene level
(Fig. 3d, Supplemental Fig. 11d). While most modules retained one
or two primary corresponding modules in the alternate cancer
type, overall the extent of overlap between modules was both
more dispersed and more diverse. The result in part reﬂects the
diversity of gene members in many ontology and signature terms,
but additionally points to the fact that while the network modules
derived from CRC and BRCA share highly signiﬁcant core gene
membership, they at the same time reﬂect a greater diversity
between the cancer types in terms of the precise patterns of co-
expression of genes related to cell function and differentiation.
Considering cancer hallmarks, recurrent modules could be
identiﬁed relating to pathways linked to cell cycle, immune
response, EMT/stroma and angiogenesis. Additional recurrent
modules were linked to co-regulated gene batteries such as the
IFN-response or growth factor signaling pathways, or structural
gene clusters such as Histone, HOX and immunoglobulin genes.
Moreover, these modules exhibited shared enrichments for
signatures of transcription factor motifs linked to gene promoters
(Supplemental Table 5).21 In BRCA the impact of chromosomal
copy number variation on gene expression in cis has been
extensively analyzed.22 Such patterns of gene co-expression were
recovered in the networks and proved highly reproducible
between BRCA and CRC, with the majority of BRCA modules
linked to speciﬁc chromosomal region having a direct counterpart
in CRC (Fig. 3c, d, Supplemental Fig. 11c, d).
Hence, the comparison between cancer types identiﬁed
principle determinants of gene co-expression patterns. These
reﬂect the impact of cancer hallmarks, functional and structural
gene batteries, and copy number variation, which are overlaid on
modules linked to the speciﬁc biology of the originating cell type.
Module neighborhoods link to epithelial differentiation pathways
Within the individual modules, the network sub-structure identi-
ﬁes genes with the highest degrees of correlation. To resolve
whether these patterns linked to discrete cell states we re-ran the
clustering and signature enrichment analysis for module genes
independently. We deﬁned the resulting sub-structure as module
neighborhoods (Fig. 4, Supplemental Fig. 12, Supplemental Table
6 & online), which illustrates another valuable feature of PGCNA,
the scalable nature of the approach.
In CRC features of epithelial differentiation are encompassed in
CRC_M3 (enterocyte) and CRC_M7 (goblet cell). The enterocyte
module encompassed neighborhoods enriched for genes linked
to the WNT-signaling pathway (neighborhood 9, CRC_M3.n9),
including LGR5,23 through to neighborhood CRC_M3.n1 enriched
for genes characteristic of the mature enterocyte state (CA1, CA4,
CD177, MS4A12 and SLC26A3), recapitulating co-expression
observed in single cell analysis of colonic epithelium (Fig. 4a,
Supplemental Fig. 12a),24 and again illustrating how the applica-
tion of the network can provide context in complex gene co-
expression data. The goblet cell module divides into 11
neighborhoods of which 5 could be assigned to known ontology
associations, for example CRC_M7.n10 linked to glycolysis and
glucose metabolism and CRC_M7.n11 linked to defense responses
(Fig. 4b, Supplemental Fig. 12b). Neighborhood CRC_M7.n8,
lacking enrichment of established ontology terms, included the
hub genes FCGBP and ST6GALNAC1 as well as SPINK4 and MUC2,
that are characteristic goblet cell markers linked to CMS3 CRC.6,24
The closely linked neighborhood CRC_M7.n1 included hub genes
REG4, AGR2 and AGR3 (Fig. 4b, online). Notably, REG4 has recently
identiﬁed as a marker of deep crypt secretory cells.25 Using the
resolution of the superﬁcial enterocyte cluster in CRC_M3.n1 as
reference, this might suggest that genes linked to REG4 in
CRC_M7.n1 identify a deep crypt secretory cell program, as
opposed to the more generic goblet cell markers in neighborhood
CRC_M7.n8.
In BRCA the luminal module (BRCA_M6) divides into nine
neighborhoods. Of these BRCA_M6.n8 is enriched for core ESR1
target genes and encompasses GATA3 and ESR1 as hub nodes (Fig.
4d, Supplemental Figure 12c, Supplemental Table 6, online).26,27
Genes that contribute to a basal-like classiﬁcation and to epithelial
biology fall in BRCA_M14. BRCA_M14.n8 includes the hub gene
SFRP1 as well as EGFR and FOXC1, PAM50 classiﬁer genes used to
deﬁne basal breast cancer (Fig. 4c, Supplemental Figure 12d,
Supplemental Table 6, online). A subset of basal breast cancer
classiﬁer genes are connected to the cytokeratin gene KRT17 in
BRCA_M14.n7 encompassing genes associated with epithelial and
epidermal differentiation and linked to normal-like breast cancer
classiﬁcation (Fig. 4c, Supplemental Table 6). Thus, the structure of
gene neighborhoods in the epithelial modules reﬂects patterns of
gene expression observed in differentiation, in both CRC and
BRCA.
Networks as multi-layered tools to explore survival associations
To provide resources that explore associations of expression with
survival, we overlaid meta-information including association of
gene expression with hazard ratio (HR) of death (Fig. 5,
Supplemental Fig. 13, online). The integration of multiple data
sources retained the ability to detect robust HR associations. In the
BRCA network, considered without histological subdivision, this
recovered the separation of good and adverse outcome between
luminal (BRCA_M6) and basal type (BRCA_M14) gene expression
(Fig. 5a, Supplemental Fig. 13a). At a module level cell cycle
(BRCA_M7) showed the strongest adverse outcome association,
which was also evident for modules linked to ampliﬁed
chromosomal regions that cluster with the cell cycle module
(such as BRCA_M24 & M37). Heterogeneity in HR association of
module genes, as shown by spread in the violin plot across the
neutral line, is a particular feature of the stem cell/EMT (BRCA_M9)
and immune response modules (BRCA_M29).
In CRC, the enterocyte (CRC_M3) and interferon response
modules (CRC_M32) were linked to good outcome, while adverse
outcome associations centered on the EMT/angiogenesis module
(CRC_M8) and modules linked to speciﬁc chromosomal regions
(Fig. 5b, Supplemental Fig. 13b). The three modules with strongest
adverse outcome association were HOXA (CRC_M34), growth
factor signaling (CRC_M21) (Supplemental Fig. 13c) and nucleo-
some (CRC_M35). In CRC the immune response module
(CRC_M26) also showed a heterogenous pattern, distinct from
the near homogenous good outcome association of the IFN
module. Thus, mapping of meta-hazard ratios both rediscovers
outcome associations linked to the primary modules that map
onto existing molecular classiﬁcation and points to less well
appreciated associations. In CRC this is particularly the case for the
adverse outcome associations with the structural gene batteries in
the HOXA and nucleosome modules, as well as the functional
gene battery of growth factor signaling which encompasses genes
M.A. Care et al.
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regulated by one of the most important pathways in this cancer
type.
Network modules provide a platform for molecular stratiﬁcation
Having validated PGCNA as a tool to interrogate the integrated
training data-sets, we next tested the modules as a platform to
explore TCGA data.7,28 To do this we wished to generate values
that would summarize the expression level of a given network
module, which could be applied across the entire data-set and on
a case by case basis. We used the 25 most representative genes
(nodes) of each module to generate module expression values
(MEV). The genes contributing to these MEVs were selected from
the genes with the highest network connectivity, which provided
an indicator of the extent to which a gene was correlated and thus
representative of other genes in the network, and focused on
genes that are variant across patients, thus most likely to
discriminate between patient subsets, but invariant across data-
sets, thus least likely to be affected by biases within data-sets.
Using these MEVs we ﬁrst tested the pattern of module expression
in the TCGA RNA-seq data by hierarchical clustering at data-set
level. In both BRCA and CRC the overall pattern of module co-
expression in RNA-seq data was closely related to that in array
derived training data-sets (Supplemental Fig. 14). This supported
the use of MEVs as a platform to summarize network level gene
expression in the TCGA data.
Next applying the MEVs at case/sample level in hierarchical
clustering segregated BRCA, initially without considering histolo-
gical type, into branches according to expression of basal, luminal
and mesenchymal related modules. In the latter this distinguished
subsets of mesenchymal from mixed mesenchymal/angiogenic
BRCA, with the latter including the majority of lobular breast
cancers (Supplemental Fig. 15a). Within these major branches
further heterogeneity was evident across other network modules,
sub-dividing the primary branches according to wider patterns of
modular gene expression. Such subdivision was also evident
within cases ﬁrst divided by histological type and then by
hierarchical clustering of MEVs (Supplemental Fig. 16a). This for
example illustrated a distinctive pattern of MEV expression in
mucinous carcinomas with strong luminal and nucleosomal gene
expression in the absence of cell cycle, EMT, angiogenesis or
immune response signals.
Extending this approach to CRC the clustering divided into
three main branches (Supplemental Fig. 15b). The ﬁrst was
characterized by low cell cycle and related chromosomal regional
module expression, accompanied by mixed immune and EMT/
angiogenesis module expression and subdivision into enterocyte
and goblet cell branches; the second enriched for highly mutated
cases was characterized by expression of the goblet cell and cell
BRCA M6
d
n8
b
CRC M7 n1
n8
CRC M3
a
n1
n9
BRCA M14
c
n7
n8
Fig. 4 Module neighborhoods provide ﬁne-grained resolution. Neighborhoods within modules are displayed by color code, interactive
version online. a CRC_M3, enterocyte module, expanded: CRC_M3.n9, WNT-signaling (blue), and CRC_M3.n1, superﬁcial enterocyte (orange). b
CRC_M7, goblet metabolic module, expanded: CRC_M7.n8, classical goblet cell and CMS3 genes (purple), and CRC_M7.n1 putative deep
secretory cell neighborhood (dark pink). c BRCA_M14, basal/normal module, expanded: BRCA_M14.n8 (blue), basal classiﬁer genes, and
BRCA_M14.n7 (pink), epithelial/epidermal differentiation. d BRCA_M6, luminal module, expanded: BRCA_M6.n8, GATA3 and ESR1
neighborhood (yellow). Related GSE results in Supplemental Fig. 12
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Expression percentile Expression dispersion Hazard ratio of deathModules
Fig. 5 Networks as multilayered tools to explore survival association. BRCA (a) and CRC (b) meta-information overlay. Left to right: module
color code, median expression percentile (relative intensity of expression) across data-sets, median expression dispersion (Quartile coefﬁcient
of dispersion, variation between samples/patients) within data-sets, and association of gene expression with meta-analysis Hazard Ratio (HR)
of death. Color scales: expression dispersion and variance blue (least) to red (most); outcome blue (low HR—good outcome) to red (high HR—
poor outcome). Lower panels ranked module level association with meta HR of death. Distribution of HR associations for module genes with
HR p-value <0.05, along with median (blue square) and IQR
M.A. Care et al.
8
npj Systems Biology and Applications (2019)    13 Published in partnership with the Systems Biology Institute
cycle and related modules; the third branch was characterized
primarily by high enterocyte module expression. This corresponds
broadly to the primary features of the consensus molecular
subtypes. However, the expression patterns of the extended
network modules illustrated how heterogeneity within these
primary branches could be mapped using MEVs to summarize
other characteristics of the CRC coexpression network. Such
heterogeneity was also evident after separation by mutational
load, notably extending to the highly mutated tumor group to
identify a subset relatively deﬁcient in immune and EMT/
angiogenesis module expression (Supplemental Fig. 16b). Further-
more, differential association of left and right sided tumors with
distinct patterns of gene expression was supported by the
modular analysis with right sided origin linked to goblet module
expression amongst both hypermutated and non-hypermutated
subsets, and left sided origin linked to enterocyte module
expression irrespective of associated EMT or immune module
expression (Supplemental Fig. 16b).
Thus, while the clustering of BRCA and CRC samples based on
MEVs reinforces the validity of key features that drive existing
paradigms of classiﬁcations, the analyses also illustrates that
considerable biological heterogeneity is present within such
clusters. As a potential solution to assess this heterogeneity the
derivation of the PGCNA network and the application of the
resulting MEVs can provide a method for summarizing the overall
expression state of a cancer sample taking into account key
representative genes from across a full network of gene
coexpression.
Data-led network modules have distinctive mutational
associations
To integrate module expression with gene mutation we ﬁrst
considered BRCA as a single entity. The MEVs provided a summary
of module level gene expression across the network which we
correlated across the data-set with the presence or absence of
mutations in the TCGA data. For BCRA as a whole this
demonstrated a primary division of enrichment or anti-
enrichment of TP53 versus CDH1, PIK3CA, GATA3, MAP3K1, KMT2C
and NCOR1 mutation (Fig. 6a). TP53 mutation positively correlated
with the cell cycle and basal modules, and some chromosomal
regional modules. In addition to the cell cycle module the immune
response and IFN modules were distinguished by additional
positive association with diverse mutational targets. The luminal,
EMT, angiogenesis and related modules were signiﬁcantly anti-
correlated with TP53 mutation and positively associated with
combinations of mutations in CDH1, PIK3CA, GATA3, MAP3K1,
KMT2C and NCOR1.
GATA3 mutations can be subdivided between DNA-binding
domain or carboxy-terminus, with the latter including frameshift
mutations. The potential value of MEVs as a tool for assessing
selective patterns of association between gene expression and
mutation is illustrated by the observation that GATA3 mutations
affecting the carboxy-terminus are selectively associated with
nucleosome module expression. Extending the analysis to BRCA
after division by histological subtype, the general pattern
observed in all BRCA irrespective of histological type was evident
when considering ductal BRCA in isolation (Supplemental Fig.
17a). Lobular BRCA is more molecularly homogenous, reﬂected in
a sparse correlation pattern, nonetheless also retaining features
observed in BRCA as a whole (Supplemental Fig. 17b).
For CRC, the pattern was impacted by the high overall mutation
load (Fig. 6b, Supplemental Fig. 17c). Associations divided around
modules linked with both TP53 and APC mutation and those that
correlated with a high mutation load across a wide range of target
genes and that were neutral or anti-correlated with TP53 and APC
mutation. This separated the enterocyte module, linked to TP53
and APC mutation, and the goblet cell module linked to high
mutation load and KRAS mutation, with KRAS mutation also
correlating with the growth factor signaling module. In CRC the
cell cycle module was not positively correlated with TP53
mutation, but instead was linked to the broad swathe of highly
mutated target genes. The modules most strongly linked to
mutation load encompassed genes from the vicinity of the TP53
on chr17p, chr18 and components of the immune response and
IFN signaling. Overall this reinforces the division of CRC into the
major molecular pathways of TP53 and APC mutation versus
hypermutational genomic instability and supports the broadly
different patterns of molecular features linked to patterns of
goblet cell or enterocyte module expression in CRC.
From the point of view of MEVs as a tool for summarizing gene
expression across the wider network representative of CRC and
BRCA, the pattern of associations observed in the TCGA data
supports the validity of this approach. While identifying novel
associations, which to our knowledge have not been previously
reported such as the linkage between nucleosome gene expres-
sion and GATA3 mutation type in BRCA, the analysis recovers
many associations that are coherent with known tumor biology.
Tumor stereotypes with mutation patterns linked to module
expression intensity
Next, we addressed the relationship between mutational proﬁle
and module expression intensity. A notable feature of this analysis
particularly evident for BRCA is the statistically signiﬁcant
association between the intensity of MEV expression and key
mutations. Thus, luminal MEV intensity showed a strong positive
correlation with CDH1, MAP3K1, GATA3 and PIK3CA mutations and
profound anti-correlation with TP53 mutation (Fig. 6c). This was
paralleled by the opposite association of cell cycle (Fig. 6d) and
basal (Fig. 6e) MEV intensity with these mutations. In this context
when used as a ranking variable the selective positive correlation
of the nucleosome module with GATA3 3′-mutations, and anti-
correlation with CDH1 mutation status, was emphasized (Fig. 6f).
As part of this speciﬁc association, both nucleosome module
expression and GATA3 3′ mutations were enriched in mucinous
BRCA (p-value 0.0004). Thus, the use of MEVs as ranking variables
illustrates the principle that extremes of module expression
associate with increasingly stereotyped tumors and more dis-
tinctive patterns of associated mutations, particularly for modules
linked to existing expression-based classiﬁcations. The potential
co-variance of mutation detection and characteristic gene
expression points both to stereotypical extremes and centrist
cases that concurrently exhibiting less characteristic expression
and mutation proﬁles.
Selective association of immune neighborhoods with mutational
proﬁle in BRCA
The interaction between host immune response and molecular
subtypes in cancer is of considerable interest. A notable feature of
the BRCA analysis was an apparent association of mutational
pattern with a module comprised of genes characteristic of mast
cells (Fig. 6a and Supplemental Fig. 17a, b). While an association of
mast cell inﬁltration with histological subtypes have been
previously described,29,30 to our knowledge the selective associa-
tion of this immune cell subset with underlying mutational state
has not been previously noted. Indeed, the discrete association of
this cell type speciﬁc module appears signiﬁcantly different from
the patterns observed for the wider immune response module in
BRCA. To further test the apparent speciﬁcity of the mast cell
module, we reasoned that the mutational association should
remain distinctive when considering the cancer immune response
at a network neighborhood level. Focusing on BRCA we therefore
integrated network modules linked to immune response features
(M18, M20, M29 & M34) and performed a neighborhood analysis.
The resulting immune neighborhood network deﬁned 14
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modules/neighborhoods of immune response and associated
gene expression (Fig. 7a). To test dominant lineage associations in
these modules we examined the relative enrichment of gene
signatures used in the bioinformatic immune deconvolution
approaches, Cibersort and Immunoscore31,32 (Supplemental Fig.
18a). This demonstrated the segregation of neighborhoods
representing core T-lineage and cytotoxic cell types (Immune_n1),
monocytes, macrophage and neutrophils (Immune_n2), M1
macrophages and activated DCs which overlaps with IFN-
response linked to MHC class I dependent antigen presentation
(Immune_n3), M0 macrophages (Immune_n7), plasma cells and B-
cells (Immune_n8), and mast cells (Immune_n10). Thus, this
neighborhood analysis identiﬁed components of cell lineage
speciﬁc gene signatures, associated with Cibersort and Immuno-
score, that are sufﬁciently correlated to emerge as distinct
modules in BCRA expression data. The remaining network
elements add to these lineage-associated neighborhoods to
identify coregulated functional gene batteries (Supplemental Fig.
18b). These include the IFN-response, which is sub-divided into a
module linked to MHC class-I antigen presentation (Immune_n3)
Fig. 6 Network modules show distinctive patterns of mutational association. Correlations of MEV with mutation status of commonly mutated
genes in TCGA data (a) BRCA & (b) CRC. Signiﬁcance of Spearman’s Rank correlation of MEV with mutation, z-score on blue to red scale;
fraction of mutated cases per gene, blue to black color scale. Hierarchical clustering for genes mutated in ≥5% BRCA and ≥10% CRC of TCGA
samples. For CRC the heatmap is truncated for display purposes (complete version Supplemental Fig. 17c). c BRCA_M6 Luminal, d BRCA_M7
cell cycle, e BRCA_M14 basal and f BRCA_M27 nucleosome, MEVs as ranking variables (red to blue color scale) for mutation distribution, z-
score and −log10 p-value for GATA3 with division into proximal (pos2; N-terminus) and distal (pos3; C-terminus), CDH1, MAP3K1, PIK3CA and
TP53. Histological: ductal (gray), lobular (white) lobular/ductal (dark blue), medullary (green), metaplastic (dark green), mucinous (black), not
reported (light blue)
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which is IFNγ response biased and overlapping with signatures of
M1 macrophages and activated DCs, and other classical IFN-
response genes, which are more IFNα response biased (Immu-
ne_n11). Other neighborhoods linked to gene batteries are those
linked to MHC class-II genes (Immune_n13), a cluster of
glutathione-μ genes (Immune_n14), and a neighborhood enriched
for components of signal transduction pathways and cytoskeletal
reorganization (Immune_n9). Interrogating these immune
neighborhoods further illustrated the selective association of
immune gene expression with associated mutations, either
considering BRCA as a whole or reﬁned to consider ductal
carcinoma in isolation (Fig. 7b). Indeed, this analysis conﬁrmed the
selective association of mast cell related gene expression
Immune_n10 with CDH1, PIK3CA and MAP3K1 mutations across
BRCA (total data). While the association between mast cell gene
expression and CDH1 mutation was as expected linked to lobular
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Fig. 7 Immune neighborhood analysis. a Immune neighborhood analysis for BRCA (across BRCA M18, M20, M29 & M34) displayed as network
summary. b Signiﬁcance of Spearman’s Rank correlation of MEV with mutation across immune neighborhoods for all BRCA left and ductal
BRCA right; z-score on blue to red scale; fraction of mutated cases per gene, blue to black color scale. Hierarchical clustering for genes
mutated in ≥5% BRCA of TCGA samples. c Ranked neighborhood level association with meta Hazard Ratio (HR) of death. Distribution of HR
associations for module genes with HR p-value <0.05, along with median (blue square) and IQR. d, e Use of immune neighborhoods
Immune_n7 (d) and Immune_n10 (e) MEVs as ranking variables (red to blue color scale) for mutation distribution, z-score and −log10 p-value
for CDH1, MAP3K1, PIK3CA and TP53: all BRCA left, ductal BRCA right
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breast cancer, PIK3CA and MAP3K1 mutations were selectively
associated with mast cell gene expression when considering only
ductal carcinoma. Within this subset mast cell gene expression
was signiﬁcantly anti-correlated with TP53 mutation. This pattern
of associations was shared only with the small set of glutathione-μ
genes encompassed in Immune_n14. Other immune gene
neighborhoods generally showed positive correlations with TP53
mutation, and in the case of neighborhoods linked to monocytes
and macrophages (n3, n7) as well as MHC class-I dependent
antigen presentation (n3), additionally showed anti-correlation
with MAP3K1 mutation state.
Consistent with these mutational and histological associations
mast cell and glutathione μ gene expression provided predictors
of good outcome in meta-hazard ratio analysis, while adverse
outcome was linked to monocyte and macrophage associated
modules (Fig. 7c). Finally using mast cell, and macrophage related
neighborhood modules as ranking variables emphasized the trend
toward stereotyped associations of expression and mutation
particularly for TP53 and MAP3K1 (Fig. 7d, e). With the intensity of
the macrophage related neighborhood Immune_n7 positively
correlated with TP53 and anti-correlated with MAP3K1, while the
intensity of mast cell related gene expression encompassed in
Immune_n10 was strongly positively correlated with MAP3K1 and
PIK3CA and anti-correlated with TP53. Thus, this analysis conﬁrms
the selective pattern of association that mast cell related gene
expression shows with underlying mutational state in BRCA
relative to other immune cell type related gene expression
proﬁles. Furthermore, the analysis illustrates how neighborhood
analysis using PGCNA can be used to home into consistent
patterns of immune gene expression in cancer tissue in a fashion
that complements approaches based on pre-deﬁned immune
subset signatures derived from puriﬁed cell subsets.
DISCUSSION
We set out to test whether the modular nature of gene co-
expression could be used to derive expression codes summarizing
diverse features of cancer biology, and whether this could be
generated from a network level view of gene co-expression using
BRCA and CRC as exemplars. These two common cancers were
selected as representative of well-deﬁned pre-existing molecular
classiﬁcations and extensive expression resources. Amongst the
features we considered desirable to achieve, were that the
networks should generate a structure that contextualizes patterns
of gene co-expression across all genes used in module generation,
and that the resolved modules of genes should identify mean-
ingful biology within and between cancer types. Furthermore, we
reasoned that by using an unsupervised approach we would be
able to test the recovery of pre-existing paradigms, and that the
resulting modules should provide the potential basis for
summarizing gene expression across the network in individual
samples.
A major challenge to achieving this aim lay in ﬁnding an
approach for edge reduction that would allow the highly complex
gene co-expression data to be reduced in complexity while
retaining information that allowed effective clustering. A striking
ﬁnding of the analysis was that the radical pruning of edges in
expression correlation matrices, retaining only the genes most
signiﬁcantly correlated with any individual index gene, prior to
network analysis with the approach know as Fast Unfolding
Communities in Large Networks (referred to in this work as
FastUnfold), allowed remarkably efﬁcient recovery of biology. This
result was not intuitive, indeed a striking feature of the
methodological development is that such edge reduction greatly
enhances the performances of the FastUnfold algorithm, which
when working on the total data-set performs signiﬁcantly less
well. Indeed, the EPG3 approach gave superior results to other
data ﬁltering methods tested—iPCC, power function or the
sigmoid function of weighted gene correlation network analysis
(WGCNA)—as assessed by a combination of module number and
gene distribution, biological enrichment, and percentage of genes
connected in the network. Interestingly, across the range of edge
reduction thresholds tested, below ten edges per gene, the
resultant parsimonious matrices yielded topologically scale-free
networks. Furthermore, in comparison with WGCNA, the combina-
tion of parsimonious correlation matrices and FastUnfold pro-
duced a greater consistency of module composition and a greater
resolution of gene signatures and ontology terms. We note that
WGCNA is widely used and a highly effective tool for analysis of
expression data-sets but is not optimized to deal with correlation
matrices derived from multiple merged expression data-sets. We
would note in this context that PGCNA can also be used to
effectively explore smaller sets of experimental data, and we have
provided an example of this in a companion paper applying the
method described here in experimental time course data related
to cellular differentiation.33
A further feature of the PGCNA approach is the computational
efﬁciency and scalable nature of the method. Firstly, this allows
effective network analysis with generally available computers
without dependence on a high-performance computing cluster.
Secondly the method can be scaled, both up to allow analysis of
very large data-sets, and down to provide a focused analysis of
subsets of genes within a wider network. The latter we refer to as a
neighborhood analysis and allows resolution of a substructure
such as patterns of gene co-expression within the luminal module
of CRC, including resolution of gene co-expression clusters seen
previously in single-cell analysis of cellular sub-populations,24 or
on the other hand in the resolution of reproducible co-expressed
gene clusters of cancer associated immune responses.12,13,31,32
Thus, the network and its modular structure may be used at
different levels to separate or coalesce cellular features.
CRC and BRCA show a remarkable communality in gene co-
expression patterns consistent with a core set of principles that
underpin patterns of co-expression in cancer. These can be
summarized as (1) genes linked to cancer hallmark features; (2)
functional gene batteries linked to either speciﬁc pathways such
as the IFN-response or growth factor receptor signaling or to
structural clusters of co-regulated genes; and (3) to co-expression
related to copy number variation. In each case these shared
drivers are associated in the networks with modules derived from
the selective biology of the originating lineage. While this pattern
is consistent with prevailing paradigms, both of the nature of
cancer hallmarks and of the impact of cis-acting modules derived
from structural genomic abnormalities,22 an important feature
provided by PGCNA is the fact that such gene expression patterns
are placed in context. One of the features we aimed for in the
network analysis was that the process of edge reduction should
both generate more visually accessible networks, and at the same
time allow all elements of the expression data used in the module
generation to be visualized. The importance of this is that the
resulting networks provide context for how genes within and
between modules are linked. The networks as an interactive
resource summarize the co-expression patterns of genes and
modules of genes as a searchable map rather than as
disconnected lists or heatmap representations. While many genes
retain only few edges in these networks, due to the nature of the
edge reduction technique, all the data for each gene is provided
as a fully accessible resource providing the correlation data for all
gene pairs across the entire sets of expression data used for
network generation.
As a platform from which to enrich molecular stratiﬁcation, the
networks recover modules that map closely onto existing
classiﬁcations for both BRCA and CRC, and place these in a wider
context. Using hub genes to generate MEVs allowed the
integration of expression with mutation proﬁles in the TCGA
resource at data-set and case-by-case level, in effect exploring the
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TCGA data from the perspective of the deep expression data
available for BRCA and CRC. Together these provide evidence that
molecular classiﬁcation may be enriched by using MEVs as a gene
expression barcode. The clustering of samples based on MEVs is
consistent with the existing paradigms of expression-based
classiﬁcations for these cancers. However, the analyses illustrate
heterogeneity within clusters of cases that map onto these
classiﬁcations, when considering wider patterns of gene expres-
sion. In the context of molecular classiﬁcation and precision
oncology there are competing goals of assigning patients to
discrete classes versus characterizing bar codes of features that
capture the wider genomic and expression features of an
individual cancer. As a potential solution to this issue the
derivation of the PGCNA network and the application of the
resulting MEVs could provide a method for summarizing the
overall expression state of a cancer sample. These MEVs take into
account key representative genes from across the entire network
of gene expression for that cancer type. Moreover, these are
derived in a data-led agnostic fashion from across multiple openly
accessible expression resources and allow comparison of informa-
tive genes between cancer types. The MEVs while utilizing many
more genes than are currently encompassed in most expression-
based classiﬁers, still remain within the range that could be
encompassed within focused gene expression platforms that
meet regulatory standards.
In comparison to previous studies of TCGA consortium, and of
the TCGA data by others, the primary difference lies in the
application of PGCNA and the resulting network modules. In this
context the rediscovery of particular associations between
mutation state and expression as assessed with MEVs provides
part of the validation of their utility. The analysis of TCGA data
with MEVs illustrates how the summary of network level
expression patterns at individual sample level can highlight
heterogeneity of expression within clusters such as the expression
variation within hypermutated CRC. Furthermore, the use of MEVs
as ranking variables illustrates the occurrence of stereotypical
associations of mutation and expression, this also illustrates the
ability to identify previously unanticipated linkages, at least to our
knowledge, such as that of nucleosome module expression with
GATA3mutation type in BRCA. Mast cell related gene expression in
the immune neighborhood analysis provides another example,
the association particularly in the ductal subset with MAP3K1 and
PIK3CA mutation and absence of TP53 mutation is distinctive
relative to other immune cell types. This raises interesting
questions as to why this particular immunological cell type should
have such distinct associations with underlying molecular
pathology.
The approach we describe here has both disease-speciﬁc and
general relevance. It provides an approach for extracting useful
networks that can be applied effectively to diverse clinical and
experimental data-sets, while also generating a mineable resource,
and illustrates how resulting network modules might be used to
sit alongside existing expression-based classiﬁcations to enhance
molecular stratiﬁcation.
METHODS
Method details
See Supplemental Fig. 1 for outline, will refer to numbers in this ﬁgure in
the sections below. For a more detailed method discussion, along with the
motivations for developing PGCNA, see the Supplemental Methods
document (Supplemental Materials page 19 onwards), for details of
software versions and data-sets see Table 1.
Expression data-sets
See Supplemental Fig. 1 part 1
For the generation of the gene correlation networks 23 breast cancer
(BRCA) and 12 colorectal cancer (CRC) gene expression data-sets were
downloaded from the Gene Expression Omnibus (BRCA, 7464 cases; 26
arrays)34–55 and (CRC, 2399 cases; 11 arrays after merging of 2).56–65 Three
of the BRCA data-sets were on two different expression platforms
(GSE3494, GSE36774 and GSE4922), these were analyzed independently,
giving a total of 26 BRCA expression data-sets. In the case of CRC two
related data-sets were merged (GSE17536), giving a total of 11 CRC data-
sets.
TCGA data-sets. For independent assessment of the network modules
two RNA-seq data-sets were downloaded from The Cancer Genome Atlas
(BRCA/CRC data-sets were downloaded on 2017.11.15 from http://
cancergenome.nih.gov/) along with the corresponding simple nucleotide
variation data (MuTect2 pipeline). The overlapping expression/mutation
samples were used for downstream analyses.
Normalization and re-annotation of data. For each data-set the probes
were re-annotated using the MyGene.info (http://mygene.info) API using
all available references (e.g. NCBI Entrez, Ensembl etc.) and any ambiguous
mappings manually assigned.66
Each data-set was quantile normalized using the R Limma package and
the probes for each gene merged by taking the median value for probe
sets with a Pearson correlation ≥0.2 and the maximum value for those with
a correlation <0.2.67
Network analysis
This discusses how the Parsimonious Gene Correlation Network Analysis
(PGCNA) approach was developed.
Gene correlation calculation. See Supplemental Fig. 1 part 2 and 3
For each expression data-set the 80% most variant genes were used to
calculate Spearman’s rank correlations for all gene pairs using the Python
scipy.stats package. The resultant p-values and correlations matrices were
merged across all data-sets for a given cancer by taking the median values
(across the sets in which the gene pairs were contained) to give a ﬁnal
median correlation matrix and its corresponding p-value matrix. Genes
present in <9 data-sets for BRCA and <4 data-sets for CRC were removed
from respective matrices. This gave a ﬁnal matrix size of 17,805 and 18,896
for BRCA and CRC, respectively. Finally, all correlations with a p-value >0.05
were set to 0 to reduce noise.
Edge reduction. See Supplemental Fig. 1 part 4
We tested a simple but aggressive edge reduction strategy as a way to
improve module discovery and network visualization. For each gene (row)
in a correlation matrix only the N most correlated Edges Per Gene (EPG)
were retained, with N ranging from 3 to 10 (<3 gives orphan modules). The
resulting matrix M, with entries written as M= (mij) was made symmetrical
by setting mij=mji for all indices i and j so that M=M
T (its transpose). For
EPG3 this reduced the nodes in BRCA from 43,231,589 to 49,199 and CRC
from 42,142,502 to 52,257, in both cases >800-fold reduction (Supple-
mental Table 1).
Data clustering. See Supplemental Fig. 1 part 5
The matrices from the edge reduction step alongside the Total matrices
were clustered using three different approaches: hierarchical clustering
using the R package fastcluster, k-means clustering using the R package
kmeans and a network level clustering using the Fast unfolding of
communities in large networks algorithm (version 0.3) referred to
subsequently herein as FastUnfold.19,68 FastUnfold was run 10,000 times
at each EPG level and the 100 best (judged by the modularity score) were
used for downstream analysis. The FastUnfold algorithm automatically
converges on a module number and therefore does not require a user
deﬁned module number.
For the k-means clustering k was set to ±1 around the module number
from the best FastUnfold solution (see Cluster selection) and for each k and
EPG 50 iterations were run.
For hierarchical clustering eight different linkage methods (average,
centroid, complete, Mcquitty, Median, Single, WardD and WardD2) were
used and the resultant dendrograms cut at ±10 around the module
number from the best FastUnfold solution giving 21 results for every input
matrix (note: only the 2 best linkage methods, WardD/WardD2, are shown
in Fig. 1a).
Comparison of edge reﬁnement approach. As well as edge-per-gene (EPG),
three other edge reﬁnement approaches were tested: iterative Pearson’s
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Table 1. Key resources table
Resource Source Identiﬁer
Deposited data
BRCA expression data 1 GEO GSE12276
BRCA expression data 2 GEO GSE16201
BRCA expression data 3 GEO GSE20194
BRCA expression data 4 GEO GSE20271
BRCA expression data 5 GEO GSE20685
BRCA expression data 6 GEO GSE21653
BRCA expression data 7 GEO GSE22093
BRCA expression data 8 GEO GSE22219
BRCA expression data 9 GEO GSE22820
BRCA expression data 10 GEO GSE24450
BRCA expression data 11 GEO GSE25066
BRCA expression data 12 GEO GSE25307
BRCA expression data 13 GEO GSE26639
BRCA expression data 14 GEO GSE2990
BRCA expression data 15 GEO GSE30682
BRCA expression data 16 GEO GSE31448
BRCA expression data 17 GEO GSE3494
BRCA expression data 18 GEO GSE36774
BRCA expression data 19 GEO GSE45725
BRCA expression data 20 GEO GSE4611
BRCA expression data 21 GEO GSE48091
BRCA expression data 22 GEO GSE4922
BRCA expression data 23 GEO GSE54002
CRC expression data 1 GEO GSE17536
CRC expression data 2 GEO GSE17537
CRC expression data 3 GEO GSE26682
CRC expression data 4 GEO GSE26682
CRC expression data 5 GEO GSE28722
CRC expression data 6 GEO GSE37892
CRC expression data 7 GEO GSE38832
CRC expression data 8 GEO GSE39582
CRC expression data 9 GEO GSE42284
CRC expression data 10 GEO GSE44076
CRC expression data 11 GEO GSE5206
CRC expression data 12 GEO GSE68468
BRCA TCGA RNA-seq TCGA Consortium https://portal.gdc.cancer.gov/projects/TCGA-BRCA
BRCA TCGA Mutation TCGA Consortium https://portal.gdc.cancer.gov/projects/TCGA-BRCA
CRC TCGA RNA-seq TCGA Consortium https://portal.gdc.cancer.gov/projects/TCGA-COAD
CRC TCGA Mutation TCGA Consortium https://portal.gdc.cancer.gov/projects/TCGA-COAD
Software and Algorithms
Fast unfolding of communities in large
networks (v0.3)
Blondel et al.19 https://sourceforge.net/projects/louvain/?source=navbar
GENE-E (v 3.0.21) N/A https://software.broadinstitute.org/GENE-E/
Gephi (v0.82) Bastian et al.69 https://gephi.org/
Gephi sigma.js library N/A https://github.com/oxfordinternetinstitute/gephi-plugins/tree/
sigmaexporter-plugin
MyGene.info Xin et al.66 http://mygene.info
Python 2.7.1 N/A https://www.anaconda.com/distribution/
R fastcluster package (v1.1.24) Müllner68 https://cran.r-project.org/web/packages/fastcluster/index.html
R Limma package (v3.34.9) Ritchie et al.67 http://bioconductor.org/packages/release/bioc/html/limma.html
R metafor package (v2.0.0) Viechtbauer71 https://cran.r-project.org/web/packages/metafor/index.html
WGCNA (v1.66) Langfelder and Horvath15 https://horvath.genetics.ucla.edu/html/CoexpressionNetwork/
Rpackages/WGCNA/
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Correlation coefﬁcient (iPCC) and the two WGCNA adjacency approaches
power/sigmoid, for a detailed discussion of this see the Supplemental
Methods document.
Comparison of edge reﬁnement and with WGCNA. In addition to
comparing the PGCNA method against other clustering methods (see
Data clustering) we validated it against the popular WGCNA gene network
analysis tool. For a detailed discussion of this see the Supplemental
Methods document.
Cluster selection. See Supplemental Fig. 1 part 6
The success of the clustering approaches was assessed by looking at the
level of biological enrichment of each module while rewarding purity
(biological enrichment in single modules) and similar (even) module sizes
(i.e. to avoid skewing to a few modules that contain many genes/
functions).
Gene signature analysis was carried out for each module, from each
clustering of the data. Then to generate a total enrichment score for a
given clustering:
Signatures were ﬁltered to retain only those with ≥5 and ≤1000 genes
with an FDR (Benjamini Hochberg) of <0.05.
For each module within a clustering, the enriched signatures were
ranked by FDR and the top 15 added to a global list of signatures for that
clustering.
A matrix was generated that contained all the z-scores for every
signature (rows) in the global list across all the modules (columns).
For each signature a fractional contribution was calculated as the row-
max-zScore/row-sum-zScores (where 1=enrichment of signature in only 1
module). Across all signatures a median factional contribution (MFC) was
calculated.
The sum of the maximum z-score per signature (row) was calculated
(ZScoreMS).
Module size skewing was assessed by calculating the normalized
Shannon entropy:
Hn pð Þ ¼ 
X
i
pi logb pi
logb n
of the module sizes. This gave a score that ranged from 1 (even module
sizes) towards 0 with increasing skewing.
A Scaled cluster enrichment score (SCES)=ZScoreMS⋅MFC⋅normalize-
dEntropy. This allowed the selection of the best FastUnfold clustering (Fig.
1a; Gene Signature Enrichment: FastUnfold). This was then used to set the
module number range in the k-means/hierarchical approaches. The
FastUnfold method outperformed the k-means/hierarchical clustering
methods across all EPG, with only the Ward-linkage hierarchical clustering
approaching a similar enrichment when using the Total data. With
increasing EPG there was a corresponding decrease in module number
with no trade-off of increased biological enrichment (Supplemental Fig. 2a
and Fig. 1a). Thus, for all downstream analysis we chose the optimal
FastUnfold EPG3 result for both cancers. However, it should be noted that
most of the recovered modules were broadly retained across the 100
FastUnfold clustering results (see Module Stability and Supplemental Fig.
2b, c). The combination of FastUnfold and EPG3 we term a Parsimonious
Gene Correlation Network Analysis (PGCNA).
Figure 3a, b and Supplemental Fig. 11a, b show visualizations of the
optimal BRCA/CRC gene signature results. As before these show the top
15 signatures per module (with ≥5 and ≤1000 genes) but are ﬁltered with
the more lenient p-value <0.01.
Module stability. The stability of modules was assessed to see how
recurrent the modules were across different clustering runs (Supplemental
Fig. 2b, c). Using the optimal clustering as a reference, for each of the 100
FastUnfold clustering, per reference module:
Find the maximum overlapping module.
Store the number of overlapping genes along with signiﬁcance (p-value)
of the overlap and increment sums for the overlapping genes.
The stability percentage per gene is simply the overlap sum (i.e. across
100 clustering runs what percentage of maximum overlapping modules is
the gene found in). The stability values per reference module were
calculated as median overlap across the 100 clustering runs.
Network visualization. See Supplemental Fig. 1 part 7
The optimal EPG3 matrix from BRCA/CRC was converted into a list of
edges and nodes and uploaded into the Gephi package (version 0.82).69
Modules were colored so that where possible signiﬁcantly overlapping
modules between BRCA and CRC shared colors. Degree and Betweenness
Centrality were calculated and the latter used to adjust node sizes. The
network layout was generated using the ForceAtlas2 approach,70 and
interactive HTML5 web visualizations exported using the sigma.js library
(https://github.com/oxfordinternetinstitute/gephi-plugins/tree/
sigmaexporter-plugin).
Network meta-data. See Supplemental Fig. 1 part 8
A number of additional features were calculated for the network genes
across the data-sets used to generate the correlation network. For each
gene the median percentile expression was calculated across all data-sets,
its dispersion across data-sets calculated as the median absolute deviation
(MAD) and its dispersion within data-sets (i.e. across patients) calculated as
the median quantile coefﬁcient of dispersion (QCOD).
The Survival library for R was used to analyze right-censored survival
data for the data-sets where this was available (n= 8 for BRCA, n= 4 for
CRC). Within each data-set the expression of each gene (as z-score) was
used as a continuous variable in a Cox Proportional Hazards model. Across
data-sets a meta-analysis was conducted by ﬁtting a ﬁxed-effect model (R
metafor package) to the hazard ratios, weighted by data-set size.
rma(yi=lnHazardRatio,sei=standardErr,weights=dataSetSize,weight-
ed=TRUE,method=“FE”).71
Module overlaps. See Supplemental Fig. 1 part 9
The overlap of the modules between the cancers at the gene and signature
level was assessed using a hypergeometric test and the overlap visualized as a
python matplotlib heatmap of −log10 p-values (Fig. 3c, d), and with the
overlap number and module size displayed (Supplemental Fig. 11c, d). The
signatures were pre-ﬁltered to p-value <0.001 and ≥ 5 and ≤ 1000 genes.
Application to TCGA data
The modules derived from the GEO ‘training data’ were used to analyze
unseen expression and mutation data from The Cancer Genome Atlas
(TCGA).
Module Expression Values. See Supplemental Fig. 1 part 10
To assign module enrichment/depletion at the patient level a summary
score was created for each module for each patient.
Within each data-set, which vary in available genes, the ﬁrst step was to
select the 25 most representative genes per module:
For every gene a connectivity score was calculated by summing its
correlations within its module. This was then weighted using expression
and dispersion information
ModCon ¼ connectivity2  percentileExpression  VarWithin  100 VarAcrossð Þ=100
Where VarWithin is the dispersion of a gene expression within data-sets
measured as the median quantile coefﬁcient of dispersion (max range
0–1), VarAcross is the dispersion of gene expression across data-sets
measured as the median absolute deviation of percentile expression (max
range 0–100). This rewards genes that have high connectivity and are
variant across patients but invariant across data-sets.
Genes were ranked by ModCon and the top 25 selected. These 25 genes
were then converted to a Module Expression Value (MEV): Per gene,
standardize (z-score) the quantile normalized log2 expression data. Per
sample (patient) sum the 25 z-scores to give a MEV.
Heatmap visualizations. See Supplemental Fig. 1 part 11
The MEV were used to create heatmap visualizations of each module at
the patient level within the BRCA and CRC TCGA data-sets. Using the Broad
GENE-E package (https://software.broadinstitute.org/GENE-E/) the MEV were
hierarchically clustered (Pearson correlations and average linkage) and
displayed along with available meta data (Supplemental Figs 15 and 16).
Mutation correlation analysis. See Supplemental Fig. 1 part 12
The relationship of mutations and modules was calculated using the
MuTect2 simple nucleotide variation (SNV) mutation data and the MEV.
The SNV data was ﬁltered to retain mutations present in >5 or >10% of
patients in BRCA and CRC respectively. Spearman’s rank correlations were
calculated between all pairs of mutated gene and module. These were
converted to z-scores to convey the ±correlation along with its
signiﬁcance. A matrix was output containing the z-scores for all gene/
modules ≥1 positive signiﬁcant (p-value <0.05) correlation (i.e. a gene need
only be signiﬁcant in one module to be included). This matrix was then
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hierarchically clustered (Pearson correlations and average linkage) using
GENE-E (Figs 6 and 7 and Supplemental Fig. 17).
For BRCA the 140 GATA3 mutations were split into three groups based
on mutation position: GATA3_Pos1 (Chr10: 8058419–8064131; n= 10),
GATA3_Pos2 (Chr10: 8069470–8069596; n= 57) and GATA3_Pos3 (Chr10:
8073734–8074229; n= 73).
Quantiﬁcation and statistical analysis
Gene signature data and enrichment analysis. A data-set of 17,211 gene
signatures was created by merging signatures downloaded from http://
lymphochip.nih.gov/signaturedb/ (SignatureDB), http://www.
broadinstitute.org/gsea/msigdb/index.jsp MSigDB V6.1 (MSigDB C1–C7
and H; excluding C5. With MIPS signatures from version 3.1 and PID
signatures from version 4 added back), http://compbio.dfci.harvard.edu/
genesigdb/ Gene Signature Database V4 (GeneSigDB), UniProt keywords
(parsed XML from http://www.uniprot.org/downloads), and locally curated
lists. A gene ontology gene set was created using an in-house python
script. This parses a gene association ﬁle (http://geneontology.org/page/
download-go-annotations) to link genes with ontology terms and then
uses the ontology structure (.obo ﬁle; http://purl.obolibrary.org/obo/go.
obo) to propagate these terms up to the root. The resultant gene set
contained 22,271 terms. The gene-ontology and gene-signatures sets were
merged to give a ﬁnal signature set of 39,482 terms.
Enrichment of gene lists for signatures was assessed using a
hypergeometric test, in which the draw is the gene list genes, the
successes are the signature genes, and the population is the genes present
on the platform.
Correlation of modules. The relationship of the modules was analyzed by
calculating the Spearman’s rank correlation for all module (as MEV) pairs
within each data-set. These were then merged across data-sets by
calculating the median correlation and p-values. A ﬁnal matrix generated
by setting all correlations with a p-value >0.05 to 0. Within GENE-E the
‘training data’ was hierarchically clustered (Pearson correlations and
average linkage) and the TCGA data displayed in the same order without
hierarchical clustering (Supplemental Fig. 14).
Data and software availability
Interactive networks and all meta-data are available at http://pgcna.gets-it.
net/. PGCNA python scripts are available at https://bitbucket.org/mcare/
pythonscripts-pgcna/src. The PGCNA python program has been imple-
mented to store data using the HDF5 data format. This allows a very small
memory footprint (<1GB) even when analyzing very large data-sets. For
example, running a 20,000 gene data-set (3GB correlation data-ﬁle) with
1000 clusterings takes ~20min, however, even an 180,000 node data-set
(240 GB correlation data-ﬁle) can be run in <1 GB or RAM, taking ~13 h to
run (including 1000 FastUnfold clusterings). This large data-set is reduced
from 16 billion edges to 540,000 (43MB), which is possible to render using
Gephi V0.9.2.
Reporting Summary
Further information on experimental design is available in the Nature
Research Reporting Summary linked to this article.
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